Roundtable: Discussing Regulatory Hurdles Specific to Drug Modalities to Understand Differences & Identify Parallels
- Bring forward the regulatory hurdles in advancing PAT tools for small molecule production
- Pinpoint the GMP compliance challenges in production of biologics
- Exploring the potential regulatory hurdles in applying PAT to CGT